Search Results for keywords:"drug products"

Found 2 results

Search Results: keywords:"drug products"

💰 Only
Oldest Newest
  • 2021-01030 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Data To Support Drug Product Communications as Used by the Food and Drug Administration
    Type:Notice
    Citation:86 FR 5219
    Reading Time:about 2 minutes

    The Food and Drug Administration (FDA) is announcing that it has submitted a proposed information collection to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act of 1995. This collection aims to support FDA's communication efforts regarding drug products by understanding public attitudes and beliefs through interviews and surveys. The FDA plans to conduct approximately 45 communication studies annually to develop effective communication messages related to drug products. No public comments were received on the proposed collection during a previous notice period.

    Simple Explanation

    The FDA wants to ask people questions to learn how they feel about medicines, so they can talk to people better about them. They plan to do this by asking different people what they think in many little studies every year.

  • 2025-04106 — Bausch & Lomb Incorporated, et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications
    Type:Notice
    Citation:90 FR 12163
    Reading Time:about a minute or two

    The Food and Drug Administration (FDA) is removing its approval for eight different abbreviated new drug applications (ANDAs), as the companies that made these drugs informed the FDA that the drugs are no longer being sold. The companies asked the FDA to cancel these approvals, and the FDA has agreed to do so as of April 14, 2025. Even though approval is being withdrawn, the decision does not prevent the companies from filing new applications in the future if desired. Also, any existing drugs from the list that are still in stock after this date can be sold until they run out, expire, or otherwise become unsuitable.

    Simple Explanation

    The FDA is stopping the approval for some medicines because the companies that made them said they don't want to sell them anymore. The companies can ask for approval again later if they change their minds.